Success Metrics

Completion Rate
0%(0/5)
Active Trials
0(0%)
Terminated
5(100%)

Phase Distribution

Ph phase_2
2
40%
Ph phase_3
3
60%

Phase Distribution

0

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
3(60.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 5 finished

Non-Completion Rate

100.0%

5 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Terminated(5)

Detailed Status

Terminated5

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (40.0%)
Phase 33 (60.0%)

Trials by Status

terminated5100%

Recent Activity

0 active trials
Showing 5 of 5
terminatedphase_2

Safety and Efficacy Study to Evaluate Proellex in the Treatment of Premenopausal Women With Symptomatic Endometriosis

NCT00556075
terminatedphase_3

Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids

NCT00702702
terminatedphase_3

Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine Fibroids

NCT00737282
terminatedphase_2

Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids

NCT00683917
terminatedphase_3

Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids

NCT00785356

Clinical Trials (5)

Showing 5 of 5 trials
NCT00556075Phase 2

Safety and Efficacy Study to Evaluate Proellex in the Treatment of Premenopausal Women With Symptomatic Endometriosis

Terminated
NCT00702702Phase 3

Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids

Terminated
NCT00737282Phase 3

Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine Fibroids

Terminated
NCT00683917Phase 2

Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids

Terminated
NCT00785356Phase 3

Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids

Terminated

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5